Lewes, DE -- (SBWIRE) -- 08/31/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Celldex Therapeutics, Inc. (NASDAQ:CLDX), Firstmerit Corp (NASDAQ:FMER), BMC Software, Inc. (NASDAQ:BMC), ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)
Celldex Therapeutics, Inc. (NASDAQ:CLDX) decreased -3.08% and closed at $21.72 on a traded volume of 1.12 million shares, in comparison to 1.49 million shares of average trading volume. So far this year, the stock is up over +312.93%.
The company has a total market capitalization of $1.76 billion and its total outstanding shares are 80.99 million.
Will CLDX Get Buyers Even After The Recent Rally? Find Out Here
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Firstmerit Corp (NASDAQ:FMER) plunged -2.80% and closed at $21.16 on a traded volume of 1.11 million shares, whereas its average trading volume is 1.07 million shares. In the last three months, the stock is up +11.13%. The Intra-day range for the stock is $21.14 and $21.76.
Will FMER Get Buyers Even After The Recent Rally? Find Out Here
FirstMerit Corporation operates as a bank holding company for FirstMerit Bank, N.A. that provides various banking, fiduciary, financial, insurance, and investment services to corporate, institutional, and individual customers.
BMC Software, Inc. (NASDAQ:BMC) jumped up +0.05% and closed at $46.00. So far in three months, the stock is up +1.46%. The 52-week range for the stock is $38.04 and $47.98 and during the previous trading session the stock touched its highest price at $46.06. Its introductory price for the day was $45.99, with the overall traded volume of 1.11 million shares.
Will BMC Continue To Move Higher? Find Out Here
BMC Software, Inc. develops software that provides system and service management solutions for enterprises in the United States and internationally.
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), after opening its shares at the price of $25.85, dropped -0.31% to close at $25.8 for the day. The stock moved on a traded volume of 1.08 million shares, in comparison to 1.22 million shares of average trading volume.
The 52-week range for the stock is $7.55 and $34.31 and during the previous trading session the stock touched its highest price at $26.25.
Will ISIS Get Buyers Even After The Recent Rally? Find Out Here
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform.
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)